This situation is not unique to cancer, as in Alzheimer’s disease, another pathological condition that activates the ISR, knockout of GCN2 also results in compensatory activation of PERK in the brains of affected animals, leading to no improvements in memory decline21. Here, EIF2AK3 is linked to early-onset autosomal dominant Alzheimer disease.